TrialThe Lancet. Infectious diseases2023

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.

Marcia M L Kho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.